Vanda Pharmaceuticals | 8-A12B: Registration of a class of securities on a national securities exchange
Apr 17 17:30 ET
Vanda Pharmaceuticals | 8-K: Current report
Apr 17 17:20 ET
Vanda Pharmaceuticals | 8-K: Current report
Apr 3 16:53 ET
Vanda Pharmaceuticals | 8-K: Current report
Mar 7 16:37 ET
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Williams Timothy
Mar 6 17:02 ET
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Moran Kevin Patrick
Mar 6 16:51 ET
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Polymeropoulos Mihael Hristos
Mar 6 16:51 ET
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Wijkstrom Joakim
Mar 6 16:51 ET
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Birznieks Gunther
Mar 6 16:50 ET
Vanda Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 4 21:16 ET
Vanda Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 4 21:16 ET
Vanda Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 4 21:11 ET
Vanda Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 4 21:11 ET
Vanda Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 4 21:11 ET
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Polymeropoulos Mihael Hristos
Feb 21 16:58 ET
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Moran Kevin Patrick
Feb 21 16:57 ET
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Wijkstrom Joakim
Feb 21 16:57 ET
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Williams Timothy
Feb 21 16:57 ET
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Birznieks Gunther
Feb 21 16:57 ET
Vanda Pharmaceuticals | 8-K: Current report
Feb 21 16:40 ET
No Data
No Data